Michael Messinger Insider Profile
11 Followers
Michael Messinger, CFO at SeaStar Medical Holding, holds 2.50K shares in SeaStar Medical Holding (Ticker: ICU), holds 19.09K shares in ContraFect (Ticker: CFRXQ). Most recently, Michael Messinger Bought ― shares of SeaStar Medical Holding on Aug 19, 2026 for an estimated value of $2.45K.
Profitable Transactions
2 out of 4 Profitable Transactions
Average Return
+14.40%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Michael Messinger holds in companies
Most Profitable Insider Trade
The most profitable trade made by Michael Messinger
Michael Messinger's Trading History
SeaStar Medical Holding
Aug 19, 2026
CFO
Informative Buy
2.45K
$7.45K
ContraFect
Dec 16, 2019
CFO
Informative Buy
1.85K
―
List of latest transactions for each holding click on a transaction to see Michael Messinger's performance on stock
You May Also Like
Michael Messinger insider profile FAQ
What is the percentage of profitable transactions made by Michael Messinger?
The percentage of profitable transactions made by Michael Messinger is 50%.
What is the average return per transaction made by Michael Messinger?
The average return per transaction made by Michael Messinger is 14.40%.
What stocks does Michael Messinger hold?
Michael Messinger holds: ICU, CFRXQ stocks.
What was Michael Messinger’s latest transaction?
Michael Messinger latest transaction was an Informative Buy of $2.45K.
What was Michael Messinger's most profitable transaction?
Michael Messinger’s most profitable transaction was an Informative Buy of CFRXQ stock on July 26, 2017. The return on the trade was 75.20%.
What is Michael Messinger's role in SeaStar Medical Holding?
Michael Messinger's role in SeaStar Medical Holding is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.